Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stephen A, Villano"'
Publikováno v:
The Journal of Infectious Diseases. 202:104-108
The experimental cytomegalovirus UL97 kinase inhibitor maribavir was used to treat 2 cases of infection in which viral mutations that conferred ganciclovir and foscarnet resistance had evolved sequentially. In one case, viral shedding was cleared wit
Autor:
David L. Thomas, Thomas C. Quinn, Ronald C. Hershow, Lynne M. Mofenson, Infants Transmission Study, F. Blaine Hollinger, Women, Clemente Diaz, Laura E. Riley, Sheldon Landesman, Katherine A. Riester, Hope Babette Tang, Stephen A. Villano, Katherine Davenny
Publikováno v:
The Journal of Infectious Diseases. 177:1480-1488
Antepartum plasma hepatitis C virus (HCV) RNA was quantified in 155 mothers coinfected with HCV and human immunodeficiency virus type 1 (HIV-1), and HCV RNA was serially assessed in their infants. Of 155 singleton infants born to HCV antibody-positiv
Autor:
Francisco M, Marty, Per, Ljungman, Genovefa A, Papanicolaou, Drew J, Winston, Roy F, Chemaly, Lynne, Strasfeld, Jo-Anne H, Young, Tulio, Rodriguez, Johan, Maertens, Michael, Schmitt, Hermann, Einsele, Augustin, Ferrant, Jeffrey H, Lipton, Stephen A, Villano, Hongzi, Chen, Michael, Boeckh, W, Rybka
Publikováno v:
The Lancet. Infectious diseases. 11(4)
Summary Background Available drugs against cytomegalovirus have adverse effects that compromise their prophylactic use in recipients of allogeneic stem-cell transplants. We assessed the safety, tolerability, and antiviral activity of oral maribavir i
Autor:
David L. Thomas, Stephen A. Villano, Kenrad E. Nelson, David Vlahov, Alfred J. Saah, Robert H. Purcell
Publikováno v:
Clinical Infectious Diseases. 25:726-728
As agencies develop guidelines for administering the newly developed hepatitis A virus (HAV) vaccine, information is needed regarding the occurrence of HAV infection in groups putatively at risk for the infection. We tested serum samples from 300 inj
Publikováno v:
Hepatology (Baltimore, Md.). 29(3)
The purpose of this investigation was to prospectively characterize acute hepatitis C virus (HCV) infections and to evaluate the hypothesis that the outcome is affected by identifiable clinical or viral factors. One hundred forty-two people with a hi
Autor:
David Vlahov, Kenrad E. Nelson, Stephen A. Villano, Sylvia Cohn, David L. Thomas, Cynthia M. Lyles
Publikováno v:
Journal of clinical microbiology. 35(12)
Between 1988 and 1996, the incidence of and risk factors for hepatitis C virus (HCV) infection were studied in a cohort of injection drug users in Baltimore, Maryland. By second-generation antibody testing of stored serum samples, 142 participants we
Publikováno v:
Clinical Infectious Diseases. 28:919-912
Autor:
Suzanne SKS Swan, William WBS Smith, Thomas TCM Marbury, Mary MS Schumacher, Carolyn CD Dougherty, Bruce BAM Mico, Stephen SAV Villano
Publikováno v:
Journal of Clinical Pharmacology; Feb2007, Vol. 47 Issue 2, p209-217, 9p
Autor:
Stephen A. Villano, John R. Ticehurst, Stuart C. Ray, Yu Ming Wang, Oliver Laeyendecker, David L. Thomas
Publikováno v:
Europe PubMed Central
We hypothesized that hepatitis C virus (HCV) persistence is related to the sequence variability of putative envelope genes. This hypothesis was tested by characterizing quasispecies in specimens collected every six months from a cohort of acutely HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be731b43ab6a6fded750076bc36ab18
http://europepmc.org/abstract/med/10074143
http://europepmc.org/abstract/med/10074143